Simeone TA, Donevan SD, Rho JM. Molecular biology and ontogeny of gamma-aminobutyric acid (GABA) receptors in the mammalian central nervous system. J Child Neurol. 2003;18:39–48 (discussion 49).
Ramamoorthi K, Lin Y. The contribution of GABAergic dysfunction to neurodevelopmental disorders. Trends Mol Med. 2011;17:452–62.
CAS PubMed PubMed Central Google Scholar
Korpi ER, Sinkkonen ST. GABA(A) receptor subtypes as targets for neuropsychiatric drug development. Pharmacol Ther. 2006;109:12–32.
Bettler B, Kaupmann K, Mosbacher J, Gassmann M. Molecular structure and physiological functions of GABA(B) receptors. Physiol Rev. 2004;84:835–67.
Nutt D. GABAA receptors: subtypes, regional distribution, and function. J Clin Sleep Med. 2006;2(2):S7-11.
Whiting PJ. GABA-A receptor subtypes in the brain: a paradigm for CNS drug discovery? Drug Discov Today. 2003;8:445–50.
Antkowiak B, Kirschfeld K. Neural mechanisms of anaesthesia [in German]. Anasthesiol Intensivmed. 2000;35:731–43.
Collins JG, Kendig JJ, Mason P. Anesthetic actions within the spinal cord: contributions to the state of general anaesthesia. Trends Neurosci. 1995;18:549–53.
McGaugh JL, Izquierdo I. The contribution of pharmacology to research on the mechanisms of memory formation. Trends Pharmacol Sci. 2000;21:208–10.
McKernan RM, Rosahl TW, Reynolds DS, et al. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype. Nat Neurosci. 2000;3:587–92.
Low K, Crestani F, Keist R, et al. Molecular and neuronal substrate for the selective attenuation of anxiety. Science. 2000;290:131–4.
Chen K, Li HZ, Ye N, Zhang J, Wang JJ. Role of GABAB receptors in GABA and baclofen-induced inhibition of adult rat cerebellar interpositus nucleus neurons in vitro. Brain Res Bull. 2005;67(4):310–8.
Dimitrijevic N, Dzitoyeva S, Satta R, et al. Drosophila GABA(B) receptors are involved in behavioral effects of gamma-hydroxybutyric acid (GHB). Eur J Pharmacol. 2005;519(3):246–52.
Dzitoyeva S, Dimitrijevic N, Manev H. Gamma-aminobutyric acid B receptor 1 mediates behavior-impairing actions of alcohol in Drosophila: adult RNA interference and pharmacological evidence. Proc Natl Acad Sci USA. 2003;100(9):5485–90.
CAS PubMed PubMed Central Google Scholar
Manev H, Dimitrijevic N. Drosophila model for in vivo pharmacological analgesia research. Eur J Pharmacol. 2004;491(2–3):207–8.
Brogden RN, Speight TM, Avery GS. Baclofen: a preliminary report of its pharmacological properties and therapeutic efficacy in spasticity. Drugs. 1974;8(1):1–14.
Alkire MT, Hudetz AG, Tononi G. Consciousness and anesthesia. Science. 2008;322:876–80.
CAS PubMed PubMed Central Google Scholar
Franks NP, Lieb WR. Molecular and cellular mechanisms of general anaesthesia. Nature. 1994;367:607–14.
Sanna E, Garau F, Harris RA. Novel properties of homomeric beta 1 gamma-aminobutyric acid type A receptors: actions of the anaesthetics propofol and pentobarbital. Mol Pharmacol. 1995;47:213–7.
Jones MV, Harrison NL, Pritchett DB, Hales TG. Modulation of the GABAA receptor by propofol is independent of the gamma subunit. J Pharmacol Exp Ther. 1995;274:962–8.
Lam DW, Reynolds JN. Modulatory and direct effects of propofol on recombinant GABAA receptors expressed in xenopus oocytes: influence of alpha- and gamma2-subunits. Brain Res. 1998;784:179–87.
Sanna E, Murgia A, Casula A, Biggio G. Differential subunit dependence of the actions of the general anaesthetics alphaxalone and etomidate at gamma-aminobutyric acid type A receptors expressed in Xenopus laevis oocytes. Mol Pharmacol. 1997;51:484–90.
Kay B, Rolly G. I.C.I. 35868, a new intravenous induction agent. Acta Anaesthesiol Belg. 1977;28:303–16.
Chen S, Rex D. Registered nurse-administered propofol sedation for endoscopy. Aliment Pharmacol Ther. 2004;19(147):55.
Ansley DM, Raedschelders K, Choi PT, et al. Propofol cardioprotection for on-pump aortocoronary bypass surgery in patients with type 2 diabetes mellitus (PRO-TECT II): a phase 2 randomized-controlled trial. Can J Anesth. 2016;63:442–53.
De Cosmo G, Cancelli I, Adduci A, et al. Changes in the hemodynamics during isoflurane and propofol anaesthesia: a comparative study. Neurol Res. 2005;27:433–5.
Johnston A, Steiner L, Chatfield D, et al. Effects of propofol on cerebral oxygenation and metabolism after head injury. Br J Anaesth. 2003;91(6):781–6.
Absalom AR, Struys M. An overview of TCI and TIVA. Ghent: Academia Press; 2005.
Aglio L, Lekowski R, Urman R. Essential clinical anaesthesia review. Cambridge: Cambridge University Press; 2015.
Russell D, Wilkes MP, Hunter SC, et al. Manual compared with target-controlled infusion of propofol. Br J Anaesth. 1995;75:562–6.
Absalom A, Kenny G. Closed-loop control of propofol anaesthesia using bispectral index: performance assessment in patients receiving computer-controlled propofol and manually controlled remifentanil infusions for minor surgery. B J Anaesth. 2003;90(6):737–41.
Leslie K, Clavisi O, Hargrove J. Target-controlled infusion versus manually-controlled infusion of propofol for general anaesthesia or sedation in adults. Cochrane Database Syst Rev. 2008;3:CD006059.
Enlund M, Berglund A, Enlund A, et al. Impact of general anaesthesia on breast cancer survival: a 5-year follow up of a pragmatic, randomised, controlled trial, the CAN-study, comparing propofol and sevoflurane. EClinicalMedicine. 2023;60:102037. https://doi.org/10.1016/j.eclinm.2023.102037. (Published 2023 Jun 9).
Article PubMed PubMed Central Google Scholar
Cao SJ, Zhang Y, Zhang YX, et al. Long-term survival in older patients given propofol or sevoflurane anaesthesia for major cancer surgery: follow-up of a multicentre randomised trial. Br J Anaesth. 2023;131(2):266–75. https://doi.org/10.1016/j.bja.2023.01.023.
Article CAS PubMed Google Scholar
Gu L, Pan X, Wang C, Wang L. The benefits of propofol on cancer treatment: decipher its modulation code to immunocytes. Front Pharmacol. 2022;13: 919636.
CAS PubMed PubMed Central Google Scholar
Chen F, Li M, Zhu X. Propofol suppresses proliferation and migration of papillary thyroid cancer cells by down-regulation of lncRNA ANRIL. Exp Mol Pathol. 2019;107:68–76.
Bennett-Guerrero E, Romeiser JL, DeMaria S, et al. General Anesthetics in CAncer REsection Surgery (GA-CARES) randomized multicenter trial of propofol vs volatile inhalational anesthesia: protocol description. Perioper Med (Lond). 2023;12(1):2. https://doi.org/10.1186/s13741-022-00290-z. (Published 2023 Jan 11).
Article PubMed PubMed Central Google Scholar
Cigognini B. Melbourne Medical School. 2022 [cited 2024 Sep 9]. VAPOR-C Trial. https://medicine.unimelb.edu.au/research-groups/critical-care-research/critcare/appmu/vapor-c.
Bachmann-Mennanga B, Ohlmer A, Heesen M. Incidence of pain after intravenous injection of a medium-/long-chain triglyceride emulsion of propofol. An observational study in 1375 patients. Arzneimittelforschung. 2003;53:621–6.
Fischer MJ, Leffler A, Niedermirtl F, et al. The general anaesthetic propofol excites nociceptors by activating TRPV1 and TRPA1 rather than GABAA receptors. J Biol Chem. 2010;285:34781–92.
Comments (0)